A phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: RTOG PA0411

被引：4

作者：

Crane, C. H. ^{[1
]}

Winter, K. ^{[2
]}

Regine, W. ^{[3
]}

Safran, H. ^{[4
]}

Rich, T. ^{[5
]}

Curran, W. ^{[6
]}

Wolff, R. ^{[1
]}

Willett, C. ^{[7
]}

机构：

[1] MD Anderson Canc Ctr, Houston, TX USA

[2] RTOG, Philadelphia, PA USA

[3] Univ Maryland, Baltimore, MD USA

[4] Brown Univ, Providence, RI 02912 USA

[5] Univ Virginia, Charlottesville, VA 22903 USA

[6] Thomas Jefferson Univ, Philadelphia, PA USA

[7] Duke Univ, Durham, NC 27706 USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2007年 / 69卷 / 03期

关键词：

D O I：

10.1016/j.ijrobp.2007.07.140

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S77 / S78

页数：2